Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Minority Interest (2016 - 2018)

Historic Minority Interest for Traws Pharma (TRAW) over the last 6 years, with Q1 2018 value amounting to $830000.0.

  • Traws Pharma's Minority Interest changed 0.0% to $830000.0 in Q1 2018 from the same period last year, while for Mar 2018 it was $830000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $830000.0 for FY2017, which is 0.0% changed from last year.
  • As of Q1 2018, Traws Pharma's Minority Interest stood at $830000.0, which was down 0.0% from $830000.0 recorded in Q4 2017.
  • Traws Pharma's 5-year Minority Interest high stood at $874000.0 for Q4 2014, and its period low was $394000.0 during Q3 2014.
  • For the 5-year period, Traws Pharma's Minority Interest averaged around $761823.5, with its median value being $830000.0 (2015).
  • Over the last 5 years, Traws Pharma's Minority Interest had its largest YoY gain of 11065.99% in 2015, and its largest YoY loss of 503.43% in 2015.
  • Quarter analysis of 5 years shows Traws Pharma's Minority Interest stood at $874000.0 in 2014, then dropped by 5.03% to $830000.0 in 2015, then changed by 0.0% to $830000.0 in 2016, then changed by 0.0% to $830000.0 in 2017, then changed by 0.0% to $830000.0 in 2018.
  • Its last three reported values are $830000.0 in Q1 2018, $830000.0 for Q4 2017, and $830000.0 during Q3 2017.